Skokie, ILNCT07213778Now EnrollingIRB Ready

Symptomatic Venous Thromboembolism (VTE) Clinical Trial in Skokie, IL

Access cutting-edge symptomatic venous thromboembolism (vte) treatment through this clinical trial at a research site in Skokie. Study-provided care at no cost to qualified participants.

Sponsored by Regeneron Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Skokie location

Preparing your pre-screening questions…

Expert Care in Skokie

Access symptomatic venous thromboembolism (vte) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related symptomatic venous thromboembolism (vte) treatment provided free

Apply for This Skokie Location

Check if you qualify for this symptomatic venous thromboembolism (vte) clinical trial in Skokie, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Skokie

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Skokie site if eligible
  4. 4Begin participation

About This Symptomatic Venous Thromboembolism (VTE) Study in Skokie

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing Venous Thromboembolism (VTE) and other related diseases after total knee replacement surgery compared to acetylsalicylic acid. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)

Sponsor: Regeneron Pharmaceuticals

Who Can Participate

Inclusion Criteria

Is undergoing a primary elective unilateral TKA
Is in good health based on laboratory safety testing as described in the protocol Key

Exclusion Criteria

Any condition that, as assessed by the investigator, may confound the results of the study or pose an additional risk to the participant by study participation
History of bleeding in the 6 months prior to randomization requiring hospitalization or transfusion; history of intracranial or intraocular bleeding, excessive operative or post-operative bleeding, and traumatic spinal or epidural anesthesia; history of bleeding diathesis (eg, hemophilia A or B, von Willebrand's Factor deficiency)
History of thromboembolic disease or thrombophilia
History of platelet dysfunction
Has received or plans to receive preoperative enoxaparin on the day prior to TKA surgery Note: Other protocol-defined Inclusion/ Exclusion criteria apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Skokie?

Yes, this clinical trial (NCT07213778) has an active research site in Skokie, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Symptomatic Venous Thromboembolism (VTE) Treatment Options in Skokie, IL

If you're searching for symptomatic venous thromboembolism (vte) treatment options in Skokie, IL, this clinical trial (NCT07213778) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Skokie research site is actively enrolling participants for this clinical trial. You'll receive care from experienced symptomatic venous thromboembolism (vte) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all symptomatic venous thromboembolism (vte) clinical trials near you to find additional studies recruiting in your area.

More Deep Vein Thrombosis Trials in Skokie, IL

See all deep vein thrombosis clinical trials recruiting in Skokie — not just this study.

Browse Deep Vein Thrombosis Trials in Skokie

Ready to Join in Skokie?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Skokie, IL